INNOVATIVE KEYS TO
HEALTH AND WELLBEING
Innokeys | News | New marketing authorization for indication locally advanced SCCHN, glioblastoma and anaplastic astrocytoma in adults, esophageal cancer, locally advanced or metastatic pancreatic cancer is approved in Kazakhstan.
New marketing authorization for indication locally advanced SCCHN, glioblastoma and anaplastic astrocytoma in adults, esophageal cancer, locally advanced or metastatic pancreatic cancer is approved in Kazakhstan.
Innokeys | March 5th, 2018

Innokeys Pte Ltd is a Singapore based limited liability company that was set up to leverage the value of innovation in the field of healthcare, especially in biopharmaceuticals.



© Copyrights Reserved INNOKEYS 2021
CONTACTS

200 Jalan Sultan #08-02
Textile Centre
Singapore 199018

INNOVATIVE KEYS
TO HEALTH AND WELLBEING